✓ Translated by DotMD AI Clinical Council Source: The Cochrane database of systematic reviews • Meta-Analysis
Verify Primary Source: NIH PubMed PMID #22592723 ↗

Meta-Analysis: Interventions for female pattern hair loss (N = 2,349)

Original Paper Title: “Interventions for female pattern hair loss”

Elena Rostova (AI Quant) Rigor Score
99 / 100
Sample Size (Participants)
N = 2,349
Evidence Classification
Meta-Analysis
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • Further direct comparison studies of minoxidil 5% applied once a day, which could improve adherence when compared to minoxidil 2% twice daily, are still required. Consideration should also be given to conducting additional well-designed, adequately-powered randomised controlled trials investigating several of the other treatment options.
  • Study Design & Sample: Meta-Analysis published in The Cochrane database of systematic reviews (N = 2349 human participants).
  • Biostatistical Rigor Score: 99/100 audited by Elena Rostova (AI Biostatistician & openFDA Quant).

What the Study Found (In Plain English)

Published in The Cochrane database of systematic reviews (2012), this meta-analysis evaluating 2,349 human participants investigated: Female pattern hair loss, or androgenic alopecia, is the most common type of hair loss affecting women. Key clinical takeaway: Further direct comparison studies of minoxidil 5% applied once a day, which could improve adherence when compared to minoxidil 2% twice daily, are still required. Consideration should also be given to conducting additional well-designed, adequately-powered randomised controlled trials investigating several of the other treatment options.

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Primary Endpoint & Quantitative Summary (The Cochrane database of systematic reviews, 2012-05-16; N = 2349; Rigor 99/100): Further direct comparison studies of minoxidil 5% applied once a day, which could improve adherence when compared to minoxidil 2% twice daily, are still required. Consideration should also be given to conducting additional well-designed, adequately-powered randomised controlled trials investigating several of the other treatment options.

Study Limitations & Caveats Before You Act

Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Meta-Analysis). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.

Related DotMD Clinical Hubs & Price Ledgers

Rx: minoxidil → Rx: stay-minoxidil-hair-regrowth-treatment-minoxidil-5 → Condition: hair-loss → Condition: hair-problems →
Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 22592723: Meta-Analysis: Interventions for female pattern hair loss (N = 2,349)

3 of 3 Free Questions Remaining